AR and prostate cancer: Dacinostat (LAQ824), a close analog of panobinostat, suppressed the Hsp90 client protein AR in LNCaP prostate cancer cells by an increase of acetylated Hsp90 levels accompanied by Hsp90-AR dissociation and AR decomposition[42].